Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Capital Leases (2024 - 2025)

Historic Capital Leases for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q1 2025 value amounting to $11000.0.

  • Artiva Biotherapeutics' Capital Leases changed N/A to $11000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $11000.0, marking a year-over-year change of. This contributed to the annual value of $44000.0 for FY2024, which is N/A changed from last year.
  • Artiva Biotherapeutics' Capital Leases amounted to $11000.0 in Q1 2025.
  • In the past 5 years, Artiva Biotherapeutics' Capital Leases registered a high of $106000.0 during Q2 2024, and its lowest value of $11000.0 during Q1 2025.